| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Endocrinology, Vol 8, 1289-1297, Copyright © 1994 by Endocrine Society
ARTICLES |
T Florio, C Rim, RE Hershberger, M Loda and PJ Stork
Vollum Institute for Advanced Biomedical Research, Oregon Health Sciences University, Portland 97201.
Somatostatin receptors are abundantly expressed on a variety of human endocrine and epithelial tumors. The ability of these receptors to couple to effector pathways that inhibit the growth of these tumor cells has prompted the use of somatostatin agonists in the treatment of human neoplasms. It has been demonstrated that somatostatin stimulates a phosphotyrosine phosphatase in human tumor cells through a receptor- mediated process. This stimulation may counteract the growth-promoting properties of growth factors and the receptor tyrosine kinases that they activate. The recent cloning and characterization of distinct somatostatin receptor subtypes raise the possibility that different receptor subtypes mediate distinct effector pathways. To determine whether cloned somatostatin receptors could mediate coupling to phosphotyrosine phosphotyrosine phosphatase activity, we examined phosphatase activity after somatotostatin activation of the rat somatostatin receptors SSTR1 and SSTR2 after their stable expression in heterologous Chinese Hamster Ovary (CHO-K1) cells. We found that stimulation of SSTR1 cells was capable of increasing phosphotyrosine phosphatase activity, despite the coupling of both receptors to the inhibition of adenylyl cyclase in these cells. This activation was characterized by an EC50 of 70 nM and was sensitive to pertussis toxin. In addition, we demonstrate that activation of phosphotyrosine phosphatase activity in pituitary cell lines correlates with the endogenous expression of the SSTR1 gene within these cells.
This article has been cited by other articles:
![]() |
F. Barbieri, A. Pattarozzi, M. Gatti, C. Aiello, A. Quintero, G. Lunardi, A. Bajetto, A. Ferrari, M. D. Culler, and T. Florio Differential efficacy of SSTR1, -2, and -5 agonists in the inhibition of C6 glioma growth in nude mice Am J Physiol Endocrinol Metab, November 1, 2009; 297(5): E1078 - E1088. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Barbieri, A. Pattarozzi, M. Gatti, C. Porcile, A. Bajetto, A. Ferrari, M. D. Culler, and T. Florio Somatostatin Receptors 1, 2, and 5 Cooperate in the Somatostatin Inhibition of C6 Glioma Cell Proliferation in Vitro via a Phosphotyrosine Phosphatase-{eta}-Dependent Inhibition of Extracellularly Regulated Kinase-1/2 Endocrinology, September 1, 2008; 149(9): 4736 - 4746. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Arena, A. Pattarozzi, A. Massa, J.-P. Esteve, R. Iuliano, A. Fusco, C. Susini, and T. Florio An Intracellular Multi-Effector Complex Mediates Somatostatin Receptor 1 Activation of Phospho-Tyrosine Phosphatase {eta} Mol. Endocrinol., January 1, 2007; 21(1): 229 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Theodoropoulou, J. Zhang, S. Laupheimer, M. Paez-Pereda, C. Erneux, T. Florio, U. Pagotto, and G. K. Stalla Octreotide, a Somatostatin Analogue, Mediates Its Antiproliferative Action in Pituitary Tumor Cells by Altering Phosphatidylinositol 3-Kinase Signaling and Inducing Zac1 Expression Cancer Res., February 1, 2006; 66(3): 1576 - 1582. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Arena, A. Pattarozzi, A. Corsaro, G. Schettini, and T. Florio Somatostatin Receptor Subtype-Dependent Regulation of Nitric Oxide Release: Involvement of Different Intracellular Pathways Mol. Endocrinol., January 1, 2005; 19(1): 255 - 267. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Massa, F. Barbieri, C. Aiello, S. Arena, A. Pattarozzi, P. Pirani, A. Corsaro, R. Iuliano, A. Fusco, G. Zona, et al. The Expression of the Phosphotyrosine Phosphatase DEP-1/PTP{eta} Dictates the Responsivity of Glioma Cells to Somatostatin Inhibition of Cell Proliferation J. Biol. Chem., July 9, 2004; 279(28): 29004 - 29012. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ferjoux, F. Lopez, J.-P. Esteve, A. Ferrand, E. Vivier, F. Vely, N. Saint-Laurent, L. Pradayrol, L. Buscail, and C. Susini Critical Role of Src and SHP-2 in sst2 Somatostatin Receptor-mediated Activation of SHP-1 and Inhibition of Cell Proliferation Mol. Biol. Cell, September 1, 2003; 14(9): 3911 - 3928. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-Y. Lin, M. G. Varma, A. Joubel, S. Madabushi, O. Lichtarge, and D. L. Barber Conserved Motifs in Somatostatin, D2-dopamine, and alpha 2B-Adrenergic Receptors for Inhibiting the Na-H Exchanger, NHE1 J. Biol. Chem., April 18, 2003; 278(17): 15128 - 15135. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Florio, S. Arena, S. Thellung, R. Iuliano, A. Corsaro, A. Massa, A. Pattarozzi, A. Bajetto, F. Trapasso, A. Fusco, et al. The Activation of the Phosphotyrosine Phosphatase {eta} (r-PTP{eta}) Is Responsible for the Somatostatin Inhibition of PC Cl3 Thyroid Cell Proliferation Mol. Endocrinol., October 1, 2001; 15(10): 1838 - 1852. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Krantic and M. Benahmed Somatostatin Inhibits Follicle-Stimulating Hormone-Induced Adenylyl Cyclase Activity and Proliferation in Immature Porcine Sertoli Cell via sst2 Receptor Biol Reprod, June 1, 2000; 62(6): 1835 - 1843. [Abstract] [Full Text] |
||||
![]() |
M. A. Sheridan, J. D. Kittilson, and B. J. Slagter Structure-Function Relationships of the Signaling System for the Somatostatin Peptide Hormone Family Integr. Comp. Biol., April 1, 2000; 40(2): 269 - 286. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Thangaraju, K. Sharma, B. Leber, D. W. Andrews, S.-H. Shen, and C. B. Srikant Regulation of Acidification and Apoptosis by SHP-1 and Bcl-2 J. Biol. Chem., October 8, 1999; 274(41): 29549 - 29557. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Florio, H. Yao, K. D. Carey, T. J. Dillon, and P. J. S. Stork Somatostatin Activation of Mitogen-Activated Protein Kinase via Somatostatin Receptor 1 (SSTR1) Mol. Endocrinol., January 1, 1999; 13(1): 24 - 37. [Abstract] [Full Text] |
||||
![]() |
R. G. Smith, L. H. T. Van der Ploeg, A. D. Howard, S. D. Feighner, K. Cheng, G. J. Hickey, M. J. Wyvratt Jr., M. H. Fisher, R. P. Nargund, and A. A. Patchett Peptidomimetic Regulation of Growth Hormone Secretion Endocr. Rev., October 1, 1997; 18(5): 621 - 645. [Abstract] [Full Text] |
||||
![]() |
F. Lopez, J.-P. Esteve, L. Buscail, N. Delesque, N. Saint-Laurent, M. Theveniau, C. Nahmias, N. Vaysse, and C. Susini The Tyrosine Phosphatase SHP-1 Associates with the sst2 Somatostatin Receptor and Is an Essential Component of sst2-mediated Inhibitory Growth Signaling J. Biol. Chem., September 26, 1997; 272(39): 24448 - 24454. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Florio, A. Scorziello, S. Thellung, S. Salzano, M. T. Berlingieri, A. Fusco, and G. Schettini Oncogene Transformation of PC Cl3 Clonal Thyroid Cell Line Induces an Autonomous Pattern of Proliferation That Correlates with a Loss of Basal and Stimulated Phosphotyrosine Phosphatase Activity Endocrinology, September 1, 1997; 138(9): 3756 - 3763. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Cordelier, J.-P. Esteve, C. Bousquet, N. Delesque, A.-M. O'Carroll, A. V. Schally, N. Vaysse, C. Susini, and L. Buscail Characterization of the antiproliferative signal mediated by the somatostatin receptor subtype sst5 PNAS, August 19, 1997; 94(17): 9343 - 9348. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Reardon, P. Dent, S. L. Wood, T. Kong, and T. W. Sturgill Activation In Vitro of Somatostatin Receptor Subtypes 2, 3, or 4 Stimulates Protein Tyrosine Phosphatase Activity in Membranes from Transfected Ras-Transformed NIH 3T3 Cells: Coexpression with Catalytically Inactive SHP-2 Blocks Responsiveness Mol. Endocrinol., July 1, 1997; 11(8): 1062 - 1069. [Abstract] [Full Text] |
||||
![]() |
R. W. Hipkin, J. Friedman, R. B. Clark, C. M. Eppler, and A. Schonbrunn Agonist-induced Desensitization, Internalization, and Phosphorylation of the sst2A Somatostatin Receptor J. Biol. Chem., May 23, 1997; 272(21): 13869 - 13876. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Florio, A. Scorziello, M. Fattore, V. D'Alto, S. Salzano, G. Rossi, M. T. Berlingieri, A. Fusco, and G. Schettini Somatostatin Inhibits PC Cl3 Thyroid Cell Proliferation through the Modulation of Phosphotyrosine Phosphatase Activity J. Biol. Chem., March 15, 1996; 271(11): 6129 - 6136. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Bhat, T. J. Thekkumkara, W. G. Thomas, K. M. Conrad, and K. M. Baker Activation of the STAT Pathway by Angiotensin II in T3CHO/AT[IMAGE] Cells J. Biol. Chem., August 11, 1995; 270(32): 19059 - 19065. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |